Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy

BJU International

Volumn 112, Issue 3, 2013, Pages 298-307

  De Castro Abreu, Andre Luis ^a   Bahn, Duke ^a,b   Leslie, Scott ^a   Shoji, Sunao ^a   Silverman, Paul ^b   Desai, Mihir M ^a   Gill, Inderbir S ^a   Ukimura, Osamu ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Graduate Medical Education   (United States)

Author keywords

cryoablation; focal therapy; prostate cancer; radiation therapy; salvage

Indexed keywords

BICALUTAMIDE; GOSERELIN; LEUPRORELIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BIOCHEMICAL FAILURE; BIOCHEMICAL FAILURE FREE SURVIVAL; BONE METASTASIS; BRACHYTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOABLATION; CRYOSURGERY DEVICE; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; FOLLOW UP; FUNCTIONAL ASSESSMENT; GLEASON SCORE; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MORBIDITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PATIENT SELECTION; POTENCY DISORDER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTON THERAPY; QUESTIONNAIRE; RECTUM FISTULA; RECURRENT CANCER; RETROSPECTIVE STUDY; SALVAGE FOCAL CRYOABLATION; SALVAGE TOTAL CRYOABLATION; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT FAILURE; ULTRASOUND SCANNER; URETHRA FISTULA; URINE INCONTINENCE;

CRYOABLATION; FOCAL THERAPY; PROSTATE CANCER; RADIATION THERAPY; SALVAGE;

AGED; AGED, 80 AND OVER; CRYOSURGERY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84879868339     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12151     Document Type: Article

References (29)

1. Grossfeld GD, Li YP, Lubeck DP, et al. Predictors of secondary cancer treatment in patients receiving local therapy for prostate cancer: data from cancer of the prostate strategic urologic research endeavor. J Urol 2002; 168: 530-535
2. Taylor LG, Canfield SE, Du XL,. Review of major adverse effects of androgen-deprivation therapy in men with prostate cancer. Cancer 2009; 115: 2388-2399
3. Mottet N, Bellmunt J, Bolla M, et al. EAU Guidelines on Prostate Cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011; 59: 572-583 [Epub 2011 Jan 25]
4. Babaian RJ, Donnelly B, Bahn D, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 2008; 180: 1993-2004
5. Gotto GT, Yunis LH, Vora K, et al. Impact of prior prostate radiation on complications after radical prostatectomy. J Urol 2010; 184: 136-142
6. Wenske S, Quarrier S, Katz AE,. Salvage cryosurgery of the prostate for failure after primary radiotherapy or cryosurgery: long-term clinical, functional, and oncologic outcomes in a large cohort at a tertiary referral centre. Eur Urol 2012; [Epub ahead of print]
7. Williams AK, Martínez CH, Lu C, et al. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer. Eur Urol 2011; 60: 405-410
8. Bahn DK, Lee F, Silverman P, et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2003; 2: 111-114
9. Ismail M, Ahmed S, Kastner C, et al. Salvage cryotherapy for recurrent prostate cancer after radiation failure: a prospective case series of the first 100 patients. BJU Int 2007; 100: 760-764
10. Eisenberg ML, Shinohara K,. Partial salvage cryoablation of the prostate for recurrent prostate cancer after radiotherapy failure. Urology 2008; 72: 1315-1318
11. Ahmed HU, Cathcart P, McCartan N, et al. Focal salvage therapy for localized prostate cancer recurrence after external beam radiotherapy. Cancer 2012; 118: 4148-4155
12. Bahn D, de Castro Abreu AL, Gill IS, et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol 2012; 62: 55-63
13. Roach M 3rd, Hanks G, Thames H Jr, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006; 65: 965-974
14. Uchio EM, Aslan M, Wells CK, et al. Impact of biochemical recurrence in prostate cancer among US veterans. Arch Intern Med 2010; 170: 1390-1395
15. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203-213. Erratum in: N Engl J Med. 2012 Aug 9; 367 (6): 582
16. Liu W, Laitinen S, Khan S, et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009; 15: 559-565. Epub 2009 Apr 12. Erratum in: Nat Med. 2009 Jul; 15 (7): 819
17. Epstein JI, Allsbrook WC Jr, Amin MB, et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-1242
18. Rogers E, Ohori M, Kassabian VS, et al. Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels. J Urol 1995; 153: 104-110
19. Arrayeh E, Westphalen AC, Kurhanewicz J, et al. Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study. Int J Radiat Oncol Biol Phys 2012; 82: e787-793
20. Pucar D, Hricak H, Shukla-Dave A, et al. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 2007; 69: 62-69
21. Huang WC, Kuroiwa K, Serio AM, et al. The anatomical and pathological characteristics of irradiated prostate cancers may influence the oncological efficacy of salvage ablative therapies. J Urol 2007; 177: 1324-1329; quiz 1591
22. Wise AM, Stamey TA, McNeal JE, et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002; 60: 264-269
23. Karavitakis M, Winkler M, Abel P, et al. Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 2011; 14: 46-52
24. Ohori M, Eastham JA, Koh H, et al. Is focal therapy reasonable in patients with early stage prostate cancer (CAP)?-An analysis of radical prostatectomy (RP) specimens. J Urol 2006; 175 (Suppl.): 507. AUA Annual Meeting, Atlanta; Abstract # 1574
25. Noguchi M, Stamey TA, McNeal JE, et al. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol 2003; 170: 459-463
26. Pisters LL, Rewcastle JC, Donnelly BJ, et al. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol 2008; 180: 559-563; discussion 563-4
27. Taira AV, Merrick GS, Galbreath RW, et al. Erectile function durability following permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 2009; 75: 639-648
28. Ukimura O, Desai MM, Palmer S, et al. 3-Dimensional elastic registration system of prostate biopsy location by real-time 3-dimensional transrectal ultrasound guidance with magnetic resonance/transrectal ultrasound image fusion. J Urol 2012; 187: 1080-1086
29. Ward JF 3rd, Rewcastle JC, Ukimura O, et al. Focal therapy for the treatment of localized prostate cancer: a potential therapeutic paradigm shift awaiting better imaging. Curr Opin Urol 2012; 22: 104-108